Many GLP-1 weight loss medications are considered for adults with obesity or adults with overweight and at least one weight-related health condition, such as high blood pressure, high cholesterol, type 2 diabetes risk, or similar metabolic concerns
[72] These episodes are often accompanied by marked distress and a feeling of loss of control over eating
Their September 2025 announcement distinguishes medication and shipping costs (covered) from consultation fees (which may need a Visa or Mastercard if you have standard CareCredit)
Many people start to see symptom improvements within 1 to 2 weeks, but full effects may take up to 6 to 8 weeks
Our results also indicated ALC was a safe agent without additional adverse effect compared with placebo
October 15, 2025: Scientific Paper Examines Kidney Injuries from Wegovy An analysis of adverse event reports from the FDA looked at the number of kidney injuries caused by Wegovy (semaglutide)